Pharmacotherapy of aggression in a 9-year-old with ADHD

Robert L. Findling; Jeffrey H. Newcorn; Richard P. Malone; Ayesha Waheed; Jefferson B. Prince; Christopher J. Kratochvil

doi:10.1097/chi.0b013e3180335b4a

Pharmacotherapy of aggression in a 9-year-old with ADHD

Robert L. Findling, Jeffrey H. Newcorn, Richard P. Malone, Ayesha Waheed, Jefferson B. Prince, Christopher J. Kratochvil

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English
Pages (from-to)	653-658
Number of pages	6
Journal	Journal of the American Academy of Child and Adolescent Psychiatry
Volume	46
Issue number	5
DOIs	https://doi.org/10.1097/chi.0b013e3180335b4a
State	Published - May 2007

Access to Document

10.1097/chi.0b013e3180335b4a

Cite this

@article{3c4c6833f9e64edaaf0a0f8043adb888,

title = "Pharmacotherapy of aggression in a 9-year-old with ADHD",

author = "Findling, {Robert L.} and Newcorn, {Jeffrey H.} and Malone, {Richard P.} and Ayesha Waheed and Prince, {Jefferson B.} and Kratochvil, {Christopher J.}",

note = "Funding Information: Disclosure: Dr. Findling receives or has received research support from, acted as a consultant to, or served on a speakers' bureau of Abbott, AstraZeneca, Bristol-Myers Squibb, Celltech-Medeva, Forest, GlaxoSmithKline, Johnson & Johnson, Lilly, New River, Novartis, Otsuka, Pfizer, Shire, Sanofi-Aventis, Solvay, and Wyeth. Dr. Malone has received investigator-initiated funding from Eli Lilly, Pfizer, and Bristol-Myers Squibb and served as a consultant to Eli Lilly. Dr. Prince is a member of the speakers' bureaus of McNeil and Janssen; has received honoraria from Shire, Novartis, and Cephalon; and has been a consultant to Shire, Novartis, Cephalon, and McNeil. Dr. Kratochvil has received grant support from, is a consultant to, and/or member of the speakers' bureaus of Eli Lilly, GlaxoSmithKline, Forest, Shire, Cephalon, Novartis, McNeil, Organon, AstraZeneca, and Pfizer. Dr. Newcorn receives research support from McNeil Pediatrics and Eli Lilly and is a consultant to, advisor to, or speaker for McNeil Pediatrics, Shire, Novartis, Eli Lilly, Cephalon, Cortex, and Pfizer. Dr. Waheed has no financial relationships to disclose. ",

year = "2007",

month = may,

doi = "10.1097/chi.0b013e3180335b4a",

language = "English",

volume = "46",

pages = "653--658",

journal = "Journal of the American Academy of Child and Adolescent Psychiatry",

issn = "0890-8567",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Pharmacotherapy of aggression in a 9-year-old with ADHD

AU - Findling, Robert L.

AU - Newcorn, Jeffrey H.

AU - Malone, Richard P.

AU - Waheed, Ayesha

AU - Prince, Jefferson B.

AU - Kratochvil, Christopher J.

N1 - Funding Information: Disclosure: Dr. Findling receives or has received research support from, acted as a consultant to, or served on a speakers' bureau of Abbott, AstraZeneca, Bristol-Myers Squibb, Celltech-Medeva, Forest, GlaxoSmithKline, Johnson & Johnson, Lilly, New River, Novartis, Otsuka, Pfizer, Shire, Sanofi-Aventis, Solvay, and Wyeth. Dr. Malone has received investigator-initiated funding from Eli Lilly, Pfizer, and Bristol-Myers Squibb and served as a consultant to Eli Lilly. Dr. Prince is a member of the speakers' bureaus of McNeil and Janssen; has received honoraria from Shire, Novartis, and Cephalon; and has been a consultant to Shire, Novartis, Cephalon, and McNeil. Dr. Kratochvil has received grant support from, is a consultant to, and/or member of the speakers' bureaus of Eli Lilly, GlaxoSmithKline, Forest, Shire, Cephalon, Novartis, McNeil, Organon, AstraZeneca, and Pfizer. Dr. Newcorn receives research support from McNeil Pediatrics and Eli Lilly and is a consultant to, advisor to, or speaker for McNeil Pediatrics, Shire, Novartis, Eli Lilly, Cephalon, Cortex, and Pfizer. Dr. Waheed has no financial relationships to disclose.

PY - 2007/5

Y1 - 2007/5

UR - http://www.scopus.com/inward/record.url?scp=34247402618&partnerID=8YFLogxK

U2 - 10.1097/chi.0b013e3180335b4a

DO - 10.1097/chi.0b013e3180335b4a

M3 - Article

AN - SCOPUS:34247402618

SN - 0890-8567

VL - 46

SP - 653

EP - 658

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

IS - 5

ER -